August 07, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
ACP has released a position paper on dietary supplements’ controversial regulations, offering FDA suggestions for a more proactive approach.In the United States, dietary supplements are considered a subcategory of food, so they are not required to undergo FDA review and approval, according to the position paper. That “inadequate regulatory framework,” according to the paper,
August 07, 2026
4 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

ACP has published living clinical guidance to help physicians select medications for patients with overweight or…

In a position statement published earlier this year, the American College of Clinical Pharmacy called for the total withdrawal of…

The FDA panel will review seven peptides and decide if they should be added to a list of substances that can be safely produced…

On the heels of a rise in private equity-owned practices, which can create unique challenges for physicians, major medical…

At the AMA’s annual meeting, members voted to strengthen the organization’s guidance for any physicians considering entering a…

An FDA committee is recommending the addition of several peptides to the 503A bulk drug substances list.The FDA’s Pharmacy…